On line Publications

Companies & Institutions Researched

This section lists all the companies that Pharmavision has researched and interviewed as primary sources.

Company
Abbott Vascular Therapy Area: Drug Delivery Abbott are a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health.
Access Pharmaceuticals (USA) Therapy Area: Drug Delivery Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that focuses on adding value to exciting product concepts in research by advancing those products through clinical development by utilizing its experienced clinical and regulatory team. Access's scientists have unique expertise in nanopolymer chemistry platform technologies, which are utilized in several of the company's R&D programs.
Angioblast Systems (USA) Therapy Area: Drug Delivery Angioblast Systems, Inc. (“Angioblast” or the “Company”) is a privately held biotechnology company formed in 2001. The Company is committed to becoming a world leader in the development and commercialization of novel therapeutic products for the treatment of cardiovascular diseases (“CVD”).
AVI BioPharma Therapy Area: Drug Delivery We are a biopharmaceutical company developing therapeutic products principally based on third generation NeuGene® antisense technology. Our principle products in development target life-threatening diseases, including cardiovascular and infectious diseases.
Brookwood Pharmaceuticals Inc Therapy Area: Drug Delivery Brookwood Pharmaceuticals' scientific team has industry-leading experience in a wide-range of drug delivery systems- with particular depth in long-acting parenterals- and is internationally recognized for its contributions to the drug-delivery field since the pioneering days of controlled release in the 1970s.
Cambridge Biostability Ltd Therapy Area: Drug Delivery Cambridge Biostability has developed the technology to create thermo-stable liquid vaccines, either in single or multivalent forms. Using pioneering, patented methods, vaccines can now be transported anywhere and administered immediately without refrigeration or re-constitution
Copernicus Therapeutics Inc Therapy Area: Drug Delivery Copernicus intends to become a leading biopharmaceutical company by utilizing its breakthrough DNA nanoparticle technologies to produce safe and effective DNA drugs. Copernicus' recent Phase I/II CF clinical trial results demonstrate that DNA nanoparticles efficiently transfer their DNA payload into the nucleus of differentiated airway cells, and do so without causing any significant toxicities. With additional funding, the Company also will be able to develop needleless, inhalation DNA drugs for the significant hemophilia A and B markets.
Emisphere Technologies, Inc Therapy Area: Drug Delivery Emisphere Technologies, Inc. is a biopharmaceutical company charting new frontiers in drug delivery. Our core business strategy is to develop oral forms of injectable drugs, either alone or with corporate partners, by applying our proprietary eligen® technology to these drugs. Emisphere has strategic alliances with world-leading pharmaceutical companies.
Glide Pharmaceutical Therapy Area: Drug Delivery Based near Oxford, UK, Glide Pharma is developing a pipeline of both Glide-branded generic products and co-developed originator products based on its proprietary Glide technology that allows the injection of drugs, vaccines and other active pharmaceutical ingredients in a solid form. Glide is an innovative new needle-free injection system that offers significant benefits and opportunities to drug developers, healthcare providers, patients and their carers.
Ichor Medical Systems (USA) Therapy Area: Drug Delivery Ichor is dedicated to the clinical application and commercialization of electroporation technology for the delivery of DNA drugs and vaccines to treat and prevent debilitating or life threatening diseases. Ichor has developed a powerful, patented electroporation technology for DNA drug delivery that will generate significant value for patients, investors and partners. We are applying our proprietary TriGrid™ Delivery System (TDS) to enable delivery of DNA drugs to address unmet medical needs in areas including therapeutic cancer vaccines, therapeutic proteins and vaccines for serious infectious disease.
Immunogen Inc Therapy Area: Drug Delivery ImmunoGen, Inc. develops targeted anticancer therapeutics. Our proprietary Tumor-Activated Prodrug (TAP) technology and strong antibody expertise form the basis for our development of our own products as well as of our partnerships with other companies.
Intercell AG Therapy Area: Drug Delivery Intercell AG is a growing biotechnology company which focuses on the design and development of novel vaccines for the prevention and treatment of infectious diseases with substantial unmet medical need. The Company develops antigens and adjuvants which are derived from its proprietary technology platforms, and has in-house GMP manufacturing capabilities.
LigoCyte Pharmaceuticals Therapy Area: Drug Delivery LigoCyte is breaking new ground in the treatment of inflammatory and infectious disease. We have produced a number of novel drug compounds to modify immune responses by focusing on cell binding interactions and their role in the immune system. Immunomodulatory drugs represent one of the most exciting areas of pharmaceutical research today, addressing the disease process itself rather than simply treating the resulting symptoms.
Maxcyte (USA) Therapy Area: Drug Delivery MaxCyte is a clinical-stage cell therapeutics company with a rapidly growing pipeline of product development partnerships in cell-based therapies. The Company's proprietary, non-viral, ex vivo cell loading technology provides safety, scalability and reproducibility capabilities which are fundamental to commercializing successful cell-based therapies.
MIV Therapeutics Inc Therapy Area: Drug Delivery MIV Therapeutics is developing a next-generation line of ultra thin, polymer-free passive and drug-eluting coatings for cardiovascular stents and a broad range of other implantable medical devices. The Company's proprietary ultra-thin, hydroxyapatite (HAp) based polymer-free coating has demonstrated excellent safety and biocompatibility in animal studies and human clinical trials for the Companies first hydroxyapatite based product the VESTASYNC Coronary Drug Eluting Stent System began in May 2007.
Nasvax (USA) Therapy Area: Drug Delivery NasVax engages in the development and commercialization of proprietary polycationic lipid-based molecules, designed to improve vaccines either by formulating an intranasal carrier platform for painless administration of vaccines or by serving as an adjuvant platform for superior response of the body's immune system.
Octoplus Therapy Area: Drug Delivery OctoPlus is a product-oriented drug delivery company focused on the development of improved pharmaceutical products with less side effects, increased patient compliance and better efficacy. Our pipeline consists of 5 products in preclinical and clinical development. Since our inception in 1995, we have established a successful track record and maintain partnerships with large and small biotech and pharma companies throughout the world.
Osiris Therapeutics Inc Therapy Area: Drug Delivery Osiris Therapeutics, Inc. is a company founded to commercialize stem cell products from adult bone marrow. These stem cells have demonstrated the ability to repair different types of tissues.
Pharmidex Pharmaceutical Services Ltd Therapy Area: Drug Delivery Pharmidex focuses on the prediction and assessment of the ability of potential new medicines to cross the permeability barrier between blood and brain – the blood-brain barrier (BBB)
Supratek Pharma Inc Therapy Area: Drug Delivery Supratek Pharma Inc. is a patient and product oriented pharmaceutical company dedicated to the discovery, rapid development and commercialization of innovative anticancer therapeutics desperately needed by cancer patients with tumors that are resistant to available therapies. Many resistant cancers are at a metastatic stage. Late-stage metastatic cancers account for the majority of cancer deaths and represent one of the major unmet medical needs world-wide.
Tekmira Pharmaceuticals Corp Therapy Area: Drug Delivery Tekmira's most advanced scientific platform is a proprietary sphingosomal drug delivery system. In developing targeted chemotherapy products, Tekmira combines already approved anticancer drugs with its proprietary drug delivery technology to make new drugs that are more effective with fewer side effects.
WestPharma Therapy Area: Drug Delivery Pharmaceutical, biopharmaceutical and medical device companies around the world rely on West Pharmaceutical Services, Inc. for standard-setting systems and device components for parenterally administered medicines. West applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines and consumer health care products.
Celera Therapy Area: Diagnostics and Imaging Celera is a diagnostics business delivering personalized disease management solutions through a combination of tests and services based on proprietary genetics discovery platforms.
Clinical Data USA Therapy Area: Diagnostics and Imaging Clinical Data, Inc. is a worldwide leader in providing comprehensive molecular and pharmacogenomics services as well as clinical diagnostics to improve patient care. The Company is organized under two worldwide divisions segmented by service offerings and varying client constituents: PGxHealth™ and Cogenics™.
Dako Therapy Area: Diagnostics and Imaging Dako is a global leader in tissue-based cancer diagnostics. Dako provides reagents, instruments and software for high quality cancer diagnosis and efficient laboratory processes. Fast, accurate test results are crucial when a patient is possibly faced with a disease. Cancer diagnostics is a complex process with many steps in the pathology laboratory susceptible to error - from inaccurate identification to an extra drop of reagents or over-fixation. The correct diagnosis hangs in the balance at each stage.
Diaceutics Therapy Area: Diagnostics and Imaging Borne of joint strategic and operational experience in both the pharmaceutical and diagnostic industries, Diaceutics mission is to build formal bridges – proprietary frameworks - for collaboration and partnering between key pharmaceutical and diagnostics players. To help engineer such decision frameworks - Diaceutics has uniquely leveraged the capabilities of - case based reasoning- (CBR), to audit and analyze precedent market case studies and investment metrics of the two business models where pharma and diagnostics have actively or passively collaborated in a continuum of care
Epigenomics Ag Therapy Area: Diagnostics and Imaging Epigenomics is a molecular diagnostics company focusing on the development and commercialization of in vitro diagnostic tests for cancer. Cancer is a dreaded and often fatal disease. However, given today’s treatment options, outcomes could potentially be greatly improved if more cancers were detected in early stages and treatments were better tailored to individual patients’ needs. This widely unmet medical need makes IVD (in vitro diagnostic) tests for cancer a segment with high future growth potential in the multi-billion euro molecular diagnostics market.
Genomic Health Therapy Area: Diagnostics and Imaging Genomic Health gives cancer patients and their healthcare providers insight needed to help make quality treatment decisions. GenomicHealth.com is designed to help patients, caregivers and healthcare professionals understand how individualized genomic profiling of tumor tissue may help improve cancer management.
Genzyme Therapy Area: Diagnostics and Imaging One of the world’s foremost biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company’s products and services are focused on rare inherited disorders, kidney disease, orthopaedics, transplant, cancer, and diagnostic testing. Genzyme’s commitment to innovation continues today with a substantial research and development program focused on these fields, as well as immune disease, infectious disease, and other areas of unmet medical need.
Kereos Therapy Area: Diagnostics and Imaging Kereos, Inc. develops targeted molecular imaging agents and therapeutics designed to detect and treat cancer and cardiovascular disease earlier and more specifically than currently possible. The specificity and unique capabilities of Kereos' molecular imaging agents enable earlier and more definitive diagnosis of disease.
Monogram Biosciences Therapy Area: Diagnostics and Imaging At Monogram Biosciences, our mission is to improve healthcare by advancing individualized medicine through the discovery and commercialization of innovative products to guide and improve the treatment of HIV, cancer and other serious diseases. Monogram Biosciences: The right therapy to the right patient at the right time.
Roche Therapy Area: Diagnostics and Imaging Roche is a leading healthcare company with a broad spectrum of innovative medical solutions. For more than 100 years, we have been active in the discovery and development, manufacturing and marketing of novel healthcare solutions. Our products and services bring significant benefit to patients from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring. Roche plays a pioneering role in personalised healthcare and is providing the first products that are tailored to the needs of specific patient groups. Our mission today and tomorrow is to create added value in healthcare by focusing on our expertise in Diagnostics and Pharmaceuticals
Synarc Therapy Area: Diagnostics and Imaging Synarc medical image-analysis, subject-recruitment, and biochemical-marker services enable life-science industry clients to execute clinical trials accurately while decreasing the time, uncertainty, and cost of product development. Synarc has contributed to the approval of more leading compounds, across a broad spectrum of therapeutic areas, than any other central imaging provider.
VirtualScopics Therapy Area: Diagnostics and Imaging VirtualScopics is the leading developer of image-related biomarkers as well as the premier provider of innovative imaging solutions utilizing biomarkers for pharmaceutical development, clinical trials, and medical device development. We provide services to the pharmaceutical, Biotechnology, and medical device industries for oncology, rheumatoid arthritis, osteoarthritis, neurology, and cardiovascular studies.
SACG Therapy Area: Diagnostics and Imaging The SACGHS Provides policy advice to the Department of Health and Human Services on the broad array of complex medical, ethical, legal, and social issues raised by the development and use of genetic technologies.
AstraZeneca Therapy Area: Diagnostics and Imaging We discover new medicines that are designed to improve the health and quality of life of patients around the world - medicines which are innovative, effective and which offer added benefits such as reduced side effects or better ways of taking the treatment. We also focus on getting the best from every medicine we make by exploring all the ways it can be used or improved.
Genentech Therapy Area: Diagnostics and Imaging Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 30 years, using human genetic information to discover, develop, manufacture and commercialize biotherapeutics that address significant unmet medical needs. Today, Genentech is among the world's leading biotech companies, with multiple products on the market for serious or life-threatening medical conditions, more than 100 projects in the pipeline and a long term plan for growth.
GSK Therapy Area: Diagnostics and Imaging GSK produce medicines that treat six major disease areas – asthma, virus control, infections, mental health, diabetes and digestive conditions. In addition, we are a leader in the important area of vaccines and are developing new treatments for cancer.
Lundbeck Therapy Area: Diagnostics and Imaging We are a research-based company. We engage in research to find new drugs for treatment of CNS disorders, includ­ing depression, schizophrenia, Alzheimer’s disease and Parkinson’s disease.
Merck Therapy Area: Diagnostics and Imaging Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company also devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service
PBM Plus Inc Therapy Area: Technology Specialists & Service Providers PBM Plus is a rapidly growing Pharmacy Benefit management company (PBM) that differentiates itself from most PBMs by being completely independent of pharmaceutical manufacturers, and pharmacies. As an independently managed subsidiary of Omnicare, we focus on creating cost effective solutions for our clients by having the freedom to develop and implement solutions that are dedicated to saving money for our clients and their individual members. PBM Plus is always committed to providing flexibility and accountability to our customers.
Revolution Health Therapy Area: Technology Specialists & Service Providers Revolution Health Group is a leading consumer-centric health company founded to transform how people approach their overall health and wellness. By putting individuals at the center of their own healthcare, Revolution Health allows them to make informed choices and offers more convenience and control over their individual healthcare decisions.
EMEA Therapy Area: Regulators & advisory committees The mission of the European Medicines Agency is to foster scientific excellence in the evaluation and supervision of medicines, for the benefit of public and animal health. Legal role The European Medicines Agency is the European Union body responsible for coordinating the existing scientific resources put at its disposal by Member States for the evaluation, supervision and pharmacovigilance of medicinal products. The Agency provides the Member States and the institutions of the EU the best-possible scientific advice on any question relating to the evaluation of the quality, safety and efficacy of medicinal products for human or veterinary use referred to it in accordance with the provisions of EU legislation relating to medicinal products.
FDA Therapy Area: Regulators & advisory committees The FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation. The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable; and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health
Bayer Healthcare Therapy Area: Pharmaceutical & Biotechnology Companies The Company combines the global activities of the divisions Animal Health, Bayer Schering Pharma and Consumer Care. More than 50,000 people are employed by Bayer HealthCare worldwide Our aim is to discover and manufacture innovative products that will improve human and animal health worldwide. Our products enhance well-being and quality of life by diagnosing, preventing and treating disease.
Merck Serono Therapy Area: Pharmaceutical & Biotechnology Companies At Merck Serono, we are actively committed to bringing therapeutic innovations to patients. We specialize in the treatment of cancer, neurodegenerative diseases, infertility, endocrine and metabolic disorders, cardiovascular diseases and other conditions with unmet medical needs
Genzyme Therapy Area: Pharmaceutical & Biotechnology Companies One of the world’s foremost biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Founded in Boston in 1981, Genzyme has grown from a small start-up to a diversified enterprise with annual revenues exceeding $3 billion and 10,000 employees in locations spanning the globe
Hoffman Roche Therapy Area: Pharmaceutical & Biotechnology Companies Roche is a leading healthcare company with a broad spectrum of innovative medical solutions. For more than 100 years, we have been active in the discovery and development, manufacturing and marketing of novel healthcare solutions. Our products and services bring significant benefit to patients from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring.
Novartis Therapy Area: Pharmaceutical & Biotechnology Companies Novartis want to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life.
Pfizer Therapy Area: Pharmaceutical & Biotechnology Companies At Pfizer, we're inspired by a single goal: your health. That's why we're dedicated to developing new, safe medicines to prevent and treat the world's most serious diseases. And why we are making them available to the people who need them most. We believe that from progress comes hope and the promise of a healthier world.
Sanofi Aventis Therapy Area: Pharmaceutical & Biotechnology Companies Sanofi-aventis brings its research creativity and innovation with just one end view: patient health